AT
Atai Life Sciences
ATAI13F as of Jun 30, 2026 · next update ~Nov 14
Limited coverage
Only 1 fund we track owns this stock, so quarterly sentiment and aggregates may be sparse.
Who's buying ATAI
Top funds mostly trimmed Atai Life Sciences in Q4 (Oct–Dec)
Buying:
FundsInsidersCongress
- Top funds0 of 1 bought more, 1 sold some. Largest: Ruane Cunniff & Goldfarb, $222K (0% of its portfolio).
- InsidersNo buys, 6 sales in 12 months.
- CongressNo trades disclosed in the last 12 months.
1 fund$221,930 held0.0% avg. weightQ4: 0 bought / 1 sold
13F reports are a snapshot as of Dec 31, 2025; funds may have traded since. Insiders often sell for personal reasons (taxes, diversification, planned sales).
Share price · market data, not from 13F reports
Q2 2026